-
Loading metrics
Open Access
Peer-reviewed
Research Article
Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers
-
Jonathan Beesley ,
Contributed equally to this work with: Jonathan Beesley, Hilda A. Pickett
* E-mail: jonathan.beesley@qimr.edu.au
Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
⨯ -
Hilda A. Pickett ,
Contributed equally to this work with: Jonathan Beesley, Hilda A. Pickett
Affiliations Cancer Research Unit, Children's Medical Research Institute, Westmead, New South Wales, Australia, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
⨯ -
Sharon E. Johnatty,
Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
⨯ -
Alison M. Dunning,
Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
⨯ -
Xiaoqing Chen,
Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
⨯ -
Jun Li,
Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
⨯ -
Kyriaki Michailidou,
Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
⨯ -
Yi Lu,
Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
⨯ -
David N. Rider,
Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
⨯ -
Rachel T. Palmieri,
Affiliation Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
⨯ -
Michael D. Stutz,
Affiliations Cancer Research Unit, Children's Medical Research Institute, Westmead, New South Wales, Australia, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
⨯ -
Diether Lambrechts,
Affiliations Vesalius Research Center, VIB, Leuven, Belgium, Vesalius Research Center, University of Leuven, Leuven, Belgium
⨯ -
Evelyn Despierre,
Affiliation Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, University of Leuven, Leuven, Belgium
⨯ -
Sandrina Lambrechts,
Affiliation Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, University of Leuven, Leuven, Belgium
⨯ -
Ignace Vergote,
Affiliation Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, University of Leuven, Leuven, Belgium
⨯ -
Jenny Chang-Claude,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Stefan Nickels,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Alina Vrieling,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Dieter Flesch-Janys,
Affiliation Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany
⨯ -
Shan Wang-Gohrke,
Affiliation Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany
⨯ -
Ursula Eilber,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Natalia Bogdanova,
Affiliations Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany, Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus, Clinics of Radiation Oncology, Hannover Medical School, Hannover, Germany
⨯ -
Natalia Antonenkova,
Affiliation Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus
⨯ -
Ingo B. Runnebaum,
Affiliation Clinics of Obstetrics and Gynaecology, Friedrich Schiller University, Jena, Germany
⨯ -
Thilo Dörk,
Affiliation Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany
⨯ -
Marc T. Goodman,
Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America
⨯ -
Galina Lurie,
Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America
⨯ -
Lynne R. Wilkens,
Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America
⨯ -
Rayna K. Matsuno,
Affiliation Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America
⨯ -
Lambertus A. Kiemeney,
Affiliations Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, Comprehensive Cancer Center, The Netherlands, Nijmegen, The Netherlands
⨯ -
Katja K. H. Aben,
Affiliations Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, Comprehensive Cancer Center, The Netherlands, Nijmegen, The Netherlands
⨯ -
Tamara Marees,
Affiliation Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
⨯ -
Leon F. A. G. Massuger,
Affiliation Department of Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
⨯ -
Brooke L. Fridley,
Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
⨯ -
Robert A. Vierkant,
Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
⨯ -
Elisa V. Bandera,
Affiliation The Cancer Institute of New Jersey/Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
⨯ -
Sara H. Olson,
Affiliation Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯ -
Irene Orlow,
Affiliation Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯ -
Lorna Rodriguez-Rodriguez,
Affiliation The Cancer Institute of New Jersey/Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
⨯ -
Linda S. Cook,
Affiliation Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada
⨯ -
Nhu D. Le,
Affiliation Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada
⨯ -
Angela Brooks-Wilson,
Affiliation Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada
⨯ -
Linda E. Kelemen,
Affiliation Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada
⨯ -
Ian Campbell,
Affiliation Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
⨯ -
Simon A. Gayther,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Susan J. Ramus,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Aleksandra Gentry-Maharaj,
Affiliation Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
⨯ -
Usha Menon,
Affiliation Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
⨯ -
Shahana Ahmed,
Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
⨯ -
Caroline Baynes,
Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
⨯ -
Paul D. Pharoah,
Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
⨯ -
kConFab Investigators,
Affiliation Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
⨯ -
Australian Ovarian Cancer Study Group,
Affiliations Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia
⨯ -
ABCTB Investigators,
Affiliation Westmead Millennium Institute, Sydney Medical School, Westmead, The University of Sydney, Sydney, New South Wales, Australia
⨯ -
Kenneth Muir,
Affiliation Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, United Kingdom
⨯ -
Artitaya Lophatananon,
Affiliation Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, United Kingdom
⨯ -
Arkom Chaiwerawattana,
Affiliation Department of Academic Support, The National Cancer Institute of Thailand, Ministry of Public Health, Nonthaburi, Thailand
⨯ -
Surapon Wiangnon,
Affiliation Department of Pediatrics, Medical School, Khon Kaen University, Khon Kaen, Thailand
⨯ -
Stuart Macgregor,
Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
⨯ -
Douglas F. Easton,
Affiliation Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
⨯ -
Roger R. Reddel,
Affiliations Cancer Research Unit, Children's Medical Research Institute, Westmead, New South Wales, Australia, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
⨯ -
Ellen L. Goode,
Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
⨯ -
Georgia Chenevix-Trench,
Affiliation Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
⨯ - [ ... ],
- on behalf of the Ovarian Cancer Association Consortium
- [ view all ]
- [ view less ]
Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers
- Jonathan Beesley,
- Hilda A. Pickett,
- Sharon E. Johnatty,
- Alison M. Dunning,
- Xiaoqing Chen,
- Jun Li,
- Kyriaki Michailidou,
- Yi Lu,
- David N. Rider,
- Rachel T. Palmieri
![PLOS](/resource/img/logo-plos.png)
- Published: September 15, 2011
- https://doi.org/10.1371/journal.pone.0024987
Saved